EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin

Barry Moran, Conor M Smith iD, Alexandra Zaborowski, Mark Ryan, Jozsef Karman, Robert W Dunstan, Kathleen M Smith, Roisin Hambly, Jana Musilova, Andreea Petrasca iD, Aurelie Fabre, Margaret O'Donnell und 6 weitere

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Barry Moran und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland (SFI), City of Dublin Skin and Cancer Hospital Charity (J.M.F.), Wellcome Trust and the Health Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment for the debilitating disease hidradenitis suppurativa (HS) is inadequate in many patients. Despite an incidence of approximately 1%, HS is often under-recognized and underdiagnosed, and is associated with a high morbidity and poor quality of life.

Objectives

To gain a better understanding of the pathogenesis of HS, in order to design new therapeutic strategies.

Methods

We employed single-cell RNA sequencing to analyse gene expression in immune cells isolated from involved HS skin vs. healthy skin. Flow cytometry was used to quantify the absolute numbers of the main immune populations. The secretion of inflammatory mediators from skin explant cultures was measured using multiplex and enzyme-linked immunosorbent assays.

Results

Single-cell RNA sequencing analysis identified a significant enrichment in the frequency of plasma cells, T helper (Th) 17 cells and dendritic cell subsets in HS skin, and the immune transcriptome was distinct and more heterogeneous than healthy skin. Flow cytometry revealed significantly increased numbers of T cells, B cells, neutrophils, dermal macrophages and dendritic cells in HS skin. Genes and pathways associated with Th17 cells, interleukin (IL)-17, IL-1β and the NLRP3 inflammasome were enhanced in HS skin, particularly in samples with a high inflammatory load. Inflammasome constituent genes principally mapped to Langerhans cells and a subpopulation of dendritic cells. The secretome of HS skin explants contained significantly increased concentrations of inflammatory mediators, including IL-1β and IL-17A, and culture with an NLRP3 inflammasome inhibitor significantly reduced the secretion of these, as well as other, key mediators of inflammation.

Conclusions

These data provide a rationale for targeting the NLRP3 inflammasome in HS using small-molecule inhibitors that are currently being tested for other indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaHumansInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinQuality of LifeSkinInflammationInflammation Mediators

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinInflammation Mediators

Autor:innen und Institutionen

  • School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Department of Surgery, St. Vincent's University Hospital, Dublin, Ireland.
  • AbbVie, Immunology Discovery Research, AbbVie Bioresearch Center, Worcester, MA, USA.
  • AbbVie, Immunology Systems Computational Biology, Cambridge Research Center, Cambridge, MA, USA.
  • Department of Dermatology, St. Vincent's University Hospital and Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.
  • Education and Research Centre, University College Dublin, Dublin, Ireland.

ORCID-Profile: Conor M Smith, Andreea Petrasca, Brian Kirby, Jean M Fletcher

Förderung

  • Science Foundation Ireland (SFI)
  • City of Dublin Skin and Cancer Hospital Charity (J.M.F.)
  • Wellcome Trust and the Health Research Board

Zitieren

APA

Moran, B., Smith, C. M., Zaborowski, A., Ryan, M., Karman, J., Dunstan, R. W., Smith, K. M., Hambly, R., Musilova, J., Petrasca, A., Fabre, A., O'Donnell, M., Hokamp, K., Mills, K. H. G., Housley, W. J., Winter, D. C., Kirby, B., & Fletcher, J. M. (2023). Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad184

Vancouver

Moran B, Smith CM, Zaborowski A, Ryan M, Karman J, Dunstan RW, et al. Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad184

BibTeX
@article{Moran2023,
  author = {Moran, Barry and Smith, Conor M and Zaborowski, Alexandra and Ryan, Mark and Karman, Jozsef and Dunstan, Robert W and Smith, Kathleen M and Hambly, Roisin and Musilova, Jana and Petrasca, Andreea and Fabre, Aurelie and O'Donnell, Margaret and Hokamp, Karsten and Mills, Kingston H G and Housley, William J and Winter, Desmond C and Kirby, Brian and Fletcher, Jean M},
  title = {Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad184}
}
Kostenlos starten →